Atlas Trials

Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies

Clinical trial NCT00526838 · TERMINATED

Trial details

NCT number
NCT00526838
Sponsor
Exelixis
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
CancerLymphoma
Start date
2007-09-01
Primary completion
2010-12-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.